Evidence map›Paper›PMID 37189037›Full record

Trial reportBMC cancer2023

The impact of the COVID-19 pandemic restrictions on the health care utilization of cancer patients.

Nico Schneider, Bernhard Strauss, Jutta Hübner, Christian Keinki, Florian Brandt, Sabine Rubai, Uwe Altmann

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. A web-based knowledge database to provide evidence-based information to cancer patients: Utilization within the PIKKO study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  7. Impact of Coronavirus Disease 2019 on the Diagnosis and Treatment of Pancreatic Cancer: An Observational Cohort Study.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nico SchneiderInstitute of Psychosocial Medicine, Psychotherapy and Psychoonocology, Jena University Hospital, Stoystrasse 3, Jena, D-07740, Germany. nico.schneider@med.uni-jena.de.
Bernhard StraussInstitute of Psychosocial Medicine, Psychotherapy and Psychoonocology, Jena University Hospital, Stoystrasse 3, Jena, D-07740, Germany.
Jutta HübnerDepartment of Haematology and Medical Oncology, Jena University Hospital, Am Klinikum 1, Jena, D-07747, Germany.
Christian KeinkiThe German Cancer Society, Kuno-Fischer-Strasse 8, Berlin, D-14057, Germany.
Florian BrandtIKK Südwest, Europaallee 3-4, Saarbrücken, D-66113, Germany.
Sabine RubaiSaarland Cancer Society, Bruchwiesenstrasse 15, Saarbrücken, D-66111, Germany.
Uwe AltmannInstitute of Psychosocial Medicine, Psychotherapy and Psychoonocology, Jena University Hospital, Stoystrasse 3, Jena, D-07740, Germany.
Jena University Hospital · DEGerman Cancer Society · DE

Funding

Innovation Fund of the Federal Joint Committee 01NVF17011
6 · The paper itself

Abstract

backgroundCOVID-19 has impacted both society and medical care. While Germany entered the first lockdown in spring 2020, the PIKKO study (Patient information, communication and competence empowerment in oncology) was still active. The intervention modules, patient navigator (PN), services of the Saarland Cancer Society (SCS), psycho-social counseling and different courses, and online knowledge database (ODB) continued to be offered, but in an adapted form. It was the aim of this supplementary survey to identify the restrictions and burdens of the pandemic containment strategies on the PIKKO patients and thus on the PIKKO study itself. Furthermore, this work shows how the PIKKO modules were used during the lockdown.

methodsAll patients in the PIKKO intervention group (IG) were invited to complete a questionnaire, n = 503. Furthermore, utilization of the SCS and log files of the ODB were analyzed. For socio-demographic data and contacts with the PN, data from the regular PIKKO surveys were used. In addition to descriptive statistics, chi²-tests, F-tests and linear regression analyses were performed.

results356 patients participated in this supplemental survey. 37.6% reported restrictions. "Restrictions on accompanying persons", "ban on visits to the wards" and "protective mouth-nose-mask" were reported as the greatest burdens. 39.0% expressed fears that the restrictions would have an impact on the course of their disease. Linear regression analyses showed differences in feelings of burden among age groups (more among < 60-year-olds), gender (more among women), children in the household (more with children), and preexisting financial stress (more with financial worries). In April 2020, there was more patient contact with PNs by phone, more SCS psycho-social counseling by phone, adapted SCS course offering, but with significantly fewer participants, and high activity on the ODB.

conclusionCancer patients in the IG reported restrictions from the pandemic containment strategies and feared an impact on their recovery. However, whether a burden is perceived as heavy depends more on gender, age, or pre-existing burdens than on whether the lockdown affects PIKKO or not. The utilization of counseling, courses or the ODB despite lockdown shows the need for such services, especially in times of crisis.

trial registrationThis study was retrospectively registered in the German Clinical Trial Register under DRKS00016703 (21 Feb 2019, retrospectively registered). https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00016703 .

Indexed as

COVID-19NeoplasmsChildCommunicable Disease ControlFemaleHumansPandemicsPatient Acceptance of Health CareCancerCOVID-19Online knowledge databasePatient navigatorPsycho-social counseling

Identifiers

PMID37189037
PMCPMC10183678
OpenAlexW4376610748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.